The upstream regulators identified in advanced-stage prostate cancer in both PC3 and DU145 cells includes (i) AGO2, (ii) SSB, and (iii) neurofibromatosis 2 (NF2), and (iv) DICER1. This evidence concerns the gene NF2 and prostate carcinoma.